Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mailuo Shutong pill for carotid atherosclerosis with vulnerable plaque
ChiCTR1900021855Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Anhui University of Chinese Medicine
- Start
- Mar 2019
- Countries
- 1
01
Overview
Phase 4 trial of mailuoshutong in carotid atheroma (CAS) (2 arms), sponsored by First Affiliated Hospital of Anhui University of Chinese Medicine. Primary endpoints: Carotid artery ultrasound-related indices, Serum inflammatory index and 1 more. Planned start Mar 2019; status: not yet recruiting.
02
Drugs
mailuoshutong
03
Conditions
carotid atheroma (CAS)
Beyond the preview
Go deeper on ChiCTR1900021855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021855.